set top-lin acceler
lower ep invest
yin yang result
cl report organ sale y/i acceler sequenti stack
beat estim unit modestli miss apac
price drove growth unit inconsist peer also price
counter inflat margin weak gm y/i om noel
wallac like ceo heir appar success call first take
key debat center around whether cl ep guid give enough
leeway invest robust innov stream anchor relaunch
colgat total hill scienc diet battl competit particularli key
emerg market suffici invest new capabl like e-commerc
org sale expect help price elta md pca base step
spend gm expect impli om hit ep guid
msd delta primarili ad spend cl indic focu disproportion
market promo capabl enhanc lower guid anticip
cl share intra-day roughli in-lin stapl expect cl
clear two challeng year view increment invest prudent
see less wiggl room margin competit dynam quell benefit ad
spend drive need increment promo support
lower ep perfect ultim risk/reward
lower ep higher organ sale
off-set lower margin disappoint big step-up spend signific
product relaunch price come cl abil turn around troubl busi
hill org sale vs balanc sheet option odd
re-acceler improv view potenti top-lin catalyst reset ep
bar creat upsid bia though trim po target
price-to-earnings multipl turn higher potenti sale catalyst reinvigor
cl improv growth year
full definit iqmethod sm measur see page
bofa merril lynch seek busi issuer cover research report
result investor awar firm may conflict interest could
affect object report investor consid report singl
factor make invest decis
refer import disclosur page analyst certif page price object
basis/risk page
net dbt
return capit employ
return equiti
iqmethod sm qualiti earn
net incom cont oper
chang work capit
full definit iqmethod sm measur see page
person household fabric pet nutrit
brand includ ajax fab softsoap palmol
mennen speed stick hill pet nutrit
colgate-palmol product market
cl heavi exposur develop market
command market share oral care posit
compani well outpac peer earn
cash flow result see cl one
attract long-term growth stori larg
impact result recent see subsid
expect growth acceler next
cl report organ sale y/i ahead estim flat result
better north america vs flat europ vs latam
vs africa/eurasia vs hill vs asia
pacif miss organ sale expect flat y/i
oper profit came ahead vs expect margin miss vs
bofaml gross margin y/i oper margin y/i
vs
ep vs bofaml/street
tabl cl y/i result commentari segment
toothpast share year date
toothpast gain share guatemala dominican republ panama chile el
salvador nicaragua remain market leader
maintain market share leadership toothpast gain franc itali greec
netherland denmark belgium
toothpast share gain australia philippin maintain market leadership
toothpast share gain turkey saudi arabia unit arab emir kenya
kazakhstan kuwait
guid organ sale ep consensu
cl guid net sale flat low-single-digit predic organ sale
growth behind increas invest higher price key brand re-
launch incl colgat total toothpast hill scienc diet pet food gross margin
expect though oper margin expect declin given increas
advertis drive expect mid-singl digit ep declin y/i
flat low-singl digit
increas sale
sale
sale
sale
depreci amort
ni non-controlling interest
ni non-controlling interest
mo end decemb
sale
sale
sale
depreci amort
ni attribut non-controlling inter
net ep dilut
net ep basic
price object base forward price-to-earnings approxim ep
estim premium large-cap stapl closer compani histor
averag rel market time cl gener best-in-class organ sale
growth demonstr abil manag difficult macro-
economic/curr environ recent result challeng organ
sale improv price ramp longer term see advantag countri
categori exposur
risk downsid increas price competit stronger us macro
volatil particularli emerg market
olivia tong cfa herebi certifi view express research report
accur reflect person view subject secur issuer also
certifi part compens directli indirectli relat
specif recommend view express research report
helen troy
qualiti earn
iqmethod smi set bofa merril lynch standard measur serv maintain global consist three broad head busi perform qualiti earn valid key featur
iqmethod consist structur detail transpar methodolog guidelin maxim effect compar valuat process identifi common pitfal
iqdatabas real-tim global research databas sourc directli equiti analyst earn model includ forecast well histor data incom statement balanc sheet cash
flow statement compani cover bofa merril lynch
iqprofil sm iqmethod sm servic mark america corpor iqdatabas regist servic mark america corpor
